CORPORATE

The meeting was a valuable opportunity for Kedrion and PPTA to strengthen our ongoing partnership

First shipments of plasma from Porto and Lisbon were received in the beginning of February

Guaranteeing equitable access to treatment is the central theme of the 2022 edition

Exclusive agreement signed for the distribution of a novel iron-based therapy

The project supported by Kedrion defines some of the key principles intended to improve patient envolvement

Scope is supplying Immunoglobulins to meet patient demand in France

Launch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen Deficiency